Performance Comparison of Agile Therapeutics, Inc. (AGRX) and Sanchez Energy Corporation (SN)

The shares of Agile Therapeutics, Inc. (NASDAQ:AGRX) and Sanchez Energy Corporation (NYSE:SN) were among the active stocks of the last trading sessions. Agile Therapeutics, Inc. (NASDAQ:AGRX) declined to -6.16% closing at the price of $0.84 whereas the shares of Sanchez Energy Corporation (NYSE:SN) declined -5.56% with the decrease of -0.13 points closing at the price of $2.21. Agile Therapeutics, Inc. has currently decrease -69.41% in its stock over the period of 6-months while its rival Sanchez Energy Corporation subtracted -30.28% in the previous 6-months.

Now we have to analyze the facts that if the stocks were worthy off investors’ money? The facts to analyze here are risks, profitability, returns and price trends.

Returns and Profitability

Profitability and returns are the main reason of investment, the investors are looking for profits that they get and return they should expect over the period of time.

The first and foremost return that is considered while making an investment is the ROI or Return on Investment. The ROI is the ratio between the profit against the cost of investment. Currently the ROI of Agile Therapeutics, Inc. (NASDAQ:AGRX) is 0% while the ROI of Sanchez Energy Corporation (NYSE:SN) is -8.9%. Another figure that is to be considered while analyzing the profitability of a share is its EBITDA margin, AGRX’s EBITDA Margin is -0.64 whereas SN’s is 11.04.

Both the profitability ratios suggest a mixed sentiment for Agile Therapeutics, Inc. (NASDAQ:AGRX) and Sanchez Energy Corporation (NYSE:SN).

EPS & Surprise Factor

Agile Therapeutics, Inc. (NASDAQ:AGRX) reported $-0.16/share EPS for the previous quarter where analysts were predicting an EPS to be $-0.17/share Thus beating the analyst Estimates with a Surprise Factor of 5.9 Percent. While, Sanchez Energy Corporation (NYSE:SN) reported EPS of $-0.26/share in the last quarter. The analysts projected EPS of $0.07/share depicting a Surprise of -471.4 Percent.

Taking a look at Earnings per Share, Agile Therapeutics, Inc. tends to be beating the analyst estimates more than Sanchez Energy Corporation. so AGRX is more profitable than SN.

Technical Analysis of Agile Therapeutics, Inc. & Sanchez Energy Corporation

Moving average convergence divergence (MACD) shows that Agile Therapeutics, Inc. (NASDAQ:AGRX) is on a PRICE RELATIVITY trend While Sanchez Energy Corporation (NYSE:SN) is on PRICE RELATIVITY trend. The trend for the past 10-days shows that the Agile Therapeutics, Inc. was in BULLISH territory and Sanchez Energy Corporation was in BEARISH territory.

AGRX’s current statistics gauge that the stock candle is BULLISH with HIGH volatility. While SN’s candle is BEARISH with MEDIUM.

EPS Growth Rate: AGRX’s 0% versus SN’s 0%

Another shareholder value can be analyzed through the EPS growth rate; the next 5 years EPS growth rate is predicted by the analysts after the analyzing the previous trends. The next 5 year EPS growth rate of Agile Therapeutics, Inc. (NASDAQ:AGRX) is predicted at 0% while Sanchez Energy Corporation (NYSE:SN) stands at 0%. These numbers suggest that SN is more suitable investment in terms of EPS growth rate.

Financial Risk and Liquidity Concerns

The current ratio and the debt ratio are the two ratios that show the investor how quickly the company is able to payout its debt and how quickly it can cover its obligations. The current ratio of AGRX stands at 2.2 while SN is at 1.1 whereas the debt ratio of the prior is 0.29 while the debt ratio of the later is 0.

The values of the both ratios suggest that AGRX is more suitable investment when the liquidity and risk is the main concern.

Analyst Recommendations

While making an investment, another main factor to consider before investing is the analyst recommendation on the scale of 1 to 5 where 1 is strong buy, 2 is buy, 3 is hold, 4 is Sell and 5 is strong sell. Analyst recommend 2.4 for AGRX and 3.1 for SN which means AGRX has Hold rating whereas SN has Sell rating.

Another recommendation of analyst that is to be considered worthy is the price target. The mare price or price trend does not suggest the suitability of a stock. The price target set by analyst is also to be considered while investing as it suggests to what extent the stock will rise or fall in the near future. The price target set for AGRX is $6 which is 86% of its current price while SN has price target of 3.27 which is 32.42% of its current price.

Valuation Ratios

Valuation is the process of determining the company’s worth for an investor, the valuation ratios give an insight to that worthiness.

AGRX currently has price to earning P/E ratio of 0 whereas SN has 0 while the forward P/E ratio for the prior stands at 0 and for the later it depicts the value of 3.46.

The price to Book P/B for AGRX is 1.08, Price to Sale is at 0 and for SN these ratios stand at 0 and 0.2.